000 01303 a2200349 4500
005 20250517194641.0
264 0 _c20191114
008 201911s 0 0 eng d
022 _a2326-6074
024 7 _a10.1158/2326-6066.CIR-17-0559
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRech, Andrew J
245 0 0 _aTumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer.
_h[electronic resource]
260 _bCancer immunology research
_c03 2018
300 _a276-287 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntigens, Neoplasm
_xgenetics
650 0 4 _aHistocompatibility Antigens Class I
_xgenetics
650 0 4 _aHistocompatibility Antigens Class II
_xgenetics
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aPeptides
_xgenetics
700 1 _aBalli, David
700 1 _aMantero, Alejandro
700 1 _aIshwaran, Hemant
700 1 _aNathanson, Katherine L
700 1 _aStanger, Ben Z
700 1 _aVonderheide, Robert H
773 0 _tCancer immunology research
_gvol. 6
_gno. 3
_gp. 276-287
856 4 0 _uhttps://doi.org/10.1158/2326-6066.CIR-17-0559
_zAvailable from publisher's website
999 _c27985194
_d27985194